EAST WINDSOR, N.J. - One lot of Mirtazapine tablets, used to treat major depressive disorder, was recalled due to a label error on its declared strength. Aurobindo ...

Mirtazapine is a central alpha-2 antagonist currently FDA-approved for the treatment of major depressive disorder. The antidepressant mirtazapine appears to be a safe and effective treatment option ...

Researchers conducted a pragmatic, randomized, placebo-controlled, phase 3 trial, in collaboration with 64 general practices in Amsterdam, to evaluate the effectiveness of low doses of the ...

Mirtazapine vs amitriptyline group had a higher risk of serious self-harm (SHR 3.04; 95% CI 1.36 to 6.79), but the risk was attenuated and no longer statistically significant after adjustment for ...

Pattern of response to antidepressants has been proposed as a method to identify patients whose improvement is more likely due to drug vs those whose improvement on drug is more likely to be a placebo ...